Drugs / AGS-003-LNG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02662634 | Mar 2016 → Mar 2018 | non-small cell lung carcinoma | GU Research Network, LLC | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AGS-003-LNG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02662634 ↗ |